Diabetes: Current and Future Developments

Author(s): Neeraj Hotchandani, Dimple Shah and Subodh J. Saggi * .

DOI: 10.2174/9789811422003120010015

Nutrition in CKD Patients Who are Obese

Pp: 196-215 (20)

Buy Chapters

* (Excluding Mailing and Handling)

  • * (Excluding Mailing and Handling)

Abstract

SHS investigation development is considered from the geographical and historical viewpoint. 3 stages are described. Within Stage 1 the work was carried out in the Department of the Institute of Chemical Physics in Chernogolovka where the scientific discovery had been made. At Stage 2 the interest to SHS arose in different cities and towns of the former USSR. Within Stage 3 SHS entered the international scene. Now SHS processes and products are being studied in more than 50 countries.

Abstract

Nutrition optimization can be a beneficial intervention in slowing down the progression of chronic kidney disease (CKD). Oftentimes, especially in obese patients with CKD, nutritional interventions are complex; involve carbohydrate and lipid restrictive strategies in addition to limitations in protein intake of poor biological value. Given the long time course CKD can take in individuals and given the unpredictable nature of CKD which varies between individuals, it is essential that periodic long term follow up with any nutritional intervention in any patient be rigorously monitored to assess adherence to dietary regimen and avoid ill consequences of too strict of a strategy. Unfortunately, long-term outcomes data of optimal dietary interventional strategies and intake of various nutrients for patients with CKD are lacking, especially for obese diabetic patients. Nevertheless, understanding the effects of adequate and inadequate nutrition in renal disease can help clinicians and patients work together to modify key risk factors that impact CKD progression. This chapter reviews the aberrancies and pathophysiological mechanisms that are associated with various microand macro-nutrient imbalances and how those imbalances can impact CKD and other comorbidities, especially in patients suffering from metabolic syndrome and obesity.

Recommended Chapters

We recommend

Favorable 70-S: Investigation Branching Arrow

Authors:Bentham Science Books